Biopharma/Biotech Analyst Chen and Biotech Analyst Watsek, along with Professor Okada of the University of California-San Francisco, Professor of Hematology Diamond at City of Hope and Randall Hyer, former SVP at Moderna, discuss the opportunity for personalized cancers vaccines (relevant companies MRK, MRNA, BNTX, GRTS) on an Analyst/Industry conference call to be held on April 20 at 1 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MRK:
- Biotech Alert: Searches spiking for these stocks today
- Prometheus downgraded to Equal Weight from Overweight at Wells Fargo
- Prometheus downgraded to Sector Perform from Outperform at RBC Capital
- Prometheus downgraded to Neutral from Overweight at Piper Sandler
- Unusually active option classes on open April 17th